Estimating Health Risks from Acrolein Exposure in the U.S.
Author Information
Author(s): Tracey J. Woodruff, Ellen M. Wells, Elizabeth W. Holt, Deborah E. Burgin, Daniel A. Axelrad
Primary Institution: U.S. Environmental Protection Agency
Hypothesis
What are the excess health risks associated with ambient concentrations of acrolein in the United States?
Conclusion
The analysis suggests that acrolein exposure could be linked to decreased respiratory function in the U.S. population.
Supporting Evidence
- Estimated ambient concentrations of acrolein exceed the reference concentration in over 90% of U.S. census tracts.
- The median additional adverse outcome for specific compliance was approximately 2.5 cases per 1,000 people.
- Acrolein exposure is linked to increased respiratory issues, including asthma exacerbation.
- Three-fourths of ambient acrolein is estimated to come from mobile sources.
- Chronic inhalation reference concentration for acrolein is set at 2 × 10−5 mg/m3.
Takeaway
This study looks at how breathing in a harmful chemical called acrolein can make it harder for people to breathe well.
Methodology
The study used dose-response modeling based on existing literature and animal studies to estimate health risks from acrolein exposure.
Potential Biases
Potential bias exists due to the reliance on animal studies and the assumptions made in modeling human exposure.
Limitations
The study relies on animal data, which may not directly translate to human responses.
Participant Demographics
The study primarily used data from male Fischer-344 rats.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website